GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Walpar Nutritions Ltd (NSE:WALPAR) » Definitions » Debt-to-EBITDA

Walpar Nutritions (NSE:WALPAR) Debt-to-EBITDA : 4.86 (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Walpar Nutritions Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Walpar Nutritions's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was ₹43.9 Mil. Walpar Nutritions's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was ₹57.8 Mil. Walpar Nutritions's annualized EBITDA for the quarter that ended in Sep. 2022 was ₹20.9 Mil. Walpar Nutritions's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 was 4.86.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Walpar Nutritions's Debt-to-EBITDA or its related term are showing as below:

NSE:WALPAR's Debt-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.705
* Ranked among companies with meaningful Debt-to-EBITDA only.

Walpar Nutritions Debt-to-EBITDA Historical Data

The historical data trend for Walpar Nutritions's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Walpar Nutritions Debt-to-EBITDA Chart

Walpar Nutritions Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22
Debt-to-EBITDA
3.82 5.37 4.60 16.48 7.25

Walpar Nutritions Semi-Annual Data
Mar18 Mar19 Mar20 Mar21 Sep21 Mar22 Sep22
Debt-to-EBITDA Get a 7-Day Free Trial N/A N/A 6.22 8.01 4.86

Competitive Comparison of Walpar Nutritions's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Walpar Nutritions's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Walpar Nutritions's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Walpar Nutritions's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Walpar Nutritions's Debt-to-EBITDA falls into.



Walpar Nutritions Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Walpar Nutritions's Debt-to-EBITDA for the fiscal year that ended in Mar. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(56.101 + 16.439) / 10.003
=7.25

Walpar Nutritions's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(43.888 + 57.79) / 20.918
=4.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Sep. 2022) EBITDA data.


Walpar Nutritions  (NSE:WALPAR) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Walpar Nutritions Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Walpar Nutritions's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Walpar Nutritions (NSE:WALPAR) Business Description

Traded in Other Exchanges
N/A
Address
Khatraj, 2nd Floor L5:377 Plot No 5, Omkar Estate, Opposite Sabarmati Gas Station, Kalol, Gandhinagar, GJ, IND, 382721
Walpar Nutritions Ltd is primarily engaged in manufacturing and trading of Pharmaceutical, Nutraceutical, Herbal, and Ayurvedic commodities.

Walpar Nutritions (NSE:WALPAR) Headlines

No Headlines